|
PGGT1B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.016500E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.15230000000433E-05 |
| Normal-vs-Stage2 |
1.661910E-02 |
| Normal-vs-Stage3 |
9.899900E-02 |
| Normal-vs-Stage4 |
9.167400E-01 |
| Stage1-vs-Stage2 |
5.516400E-01 |
| Stage1-vs-Stage3 |
3.211800E-01 |
| Stage1-vs-Stage4 |
8.753900E-02 |
| Stage2-vs-Stage3 |
7.982200E-01 |
| Stage2-vs-Stage4 |
3.460400E-01 |
| Stage3-vs-Stage4 |
4.048200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.88229999999301E-05 |
| Normal-vs-AfricanAmerican |
2.501400E-03 |
| Normal-vs-Asian |
7.663800E-01 |
| Caucasian-vs-AfricanAmerican |
7.397800E-01 |
| Caucasian-vs-Asian |
3.270600E-01 |
| AfricanAmerican-vs-Asian |
3.581200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.75718999999575E-05 |
| Normal-vs-Female |
7.139600E-02 |
| Male-vs-Female |
1.340340E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.084200E-02 |
| Normal-vs-Extreme_Weight |
9.71539999999882E-05 |
| Normal-vs-Obese |
7.401100E-04 |
| Normal-vs-Extreme_Obese |
1.307050E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.759600E-01 |
| Normal_Weight-vs-Obese |
5.841200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.897800E-01 |
| Extreme_Weight-vs-Obese |
5.176400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.066400E-01 |
| Obese-vs-Extreme_Obese |
9.763200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.274200E-02 |
| Normal-vs-Age(41-60Yrs) |
2.583400E-03 |
| Normal-vs-Age(61-80Yrs) |
4.03720000000662E-05 |
| Normal-vs-Age(81-100Yrs) |
9.599600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.488600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.369200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.770600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.647770E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.458200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.706400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.89449999998814E-06 |
| Normal-VS-Type2 PRCC |
1.145570E-01 |
| Normal-VS-KIRP CIMP |
2.707800E-02 |
| Normal-VS-Unclassified PRCC |
1.847790E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.751500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.378000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.489800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.198200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.193800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.530800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.217600E-04 |
| Normal-vs-N1 |
2.987800E-01 |
| Normal-vs-N2 |
3.421700E-02 |
| N0-vs-N1 |
1.285430E-01 |
| N0-vs-N2 |
8.354200E-01 |
| N1-vs-N2 |
3.614800E-01 |
|
|
